{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:59:43Z","timestamp":1790704783739,"version":"4.1.0"},"reference-count":72,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmazie"],"abstract":"<jats:p>Pharmaceutical quality control laboratories are essential to ensuring the safety and quality of medicines. The World Health Organization (WHO) Good Practices for Pharmaceutical Quality Control Laboratories (GPPQCL) provide a framework for establishing reliable and inspection-ready laboratory systems. This review critically evaluates the implementation of GPPQCL, examining practical challenges, policy gaps, and variability in adoption across different settings. A structured narrative approach was used to analyze World Health Organization (WHO) guidance, international standards, and relevant literature (2010\u20132026), with an emphasis on inspection expectations and real-world practices. Effective implementation depends on robust quality management systems, validated methods, competent personnel, and strong data integrity practices. However, challenges such as infrastructure limitations, method standardization, and uneven data governance persist, particularly in resource-limited environments. Evidence from WHO-prequalified laboratories shows that risk-based implementation and capacity-building initiatives can support compliance and international recognition. Overall, GPPQCL provides a practical framework for strengthening laboratory systems, enhancing regulatory confidence, and supporting global efforts to ensure the quality of medicines.<\/jats:p>","DOI":"10.31083\/pharmazie51355","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:05:53Z","timestamp":1790701553000},"source":"Crossref","is-referenced-by-count":0,"title":["Strengthening Pharmaceutical Quality Control Laboratories: Inspection-Ready Implementation of the World Health Organization Good Practices for Pharmaceutical Quality Control Laboratories and Pathways to Prequalification"],"prefix":"10.31083","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1381-1369","authenticated-orcid":true,"given":"Imad Osman","family":"Abu Reid","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, International University of Africa, 11111 Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. TRS 1052 \u2013 Annex 4: WHO good practices for pharmaceutical quality control laboratories. WHO Technical Report Series. 2024. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240091030 (Accessed: 13 March 2026)."},{"key":"ref2","unstructured":"International Organization for Standardization. ISO\/IEC 17025:2017: General requirements for the competence of testing and calibration laboratories. ISO: Geneva. 2017."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Badrick T, Anetor J. Preparing medical laboratories in low- and middle-income countries for a sustainable future. African Journal of Laboratory Medicine. 2025; 14: 2734.","DOI":"10.4102\/ajlm.v14i1.2734"},{"key":"ref4","unstructured":"World Health Organization. Prequalification of quality control laboratories: procedure for assessing the acceptability, in principle, of quality control laboratories for use by United Nations agencies. 2017. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/258720\/9789241210034-eng.pdf?sequence=1&isAllowed=y (Accessed: 13 March 2026)."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Coyne PE. The World Health Organization Prequalification Programme-playing an essential role in assuring quality medical products. International Health. 2019; 11: 79\u201380.","DOI":"10.1093\/inthealth\/ihy095"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Dellepiane N, Wood D. Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives. Vaccine. 2015; 33: 52\u201361.","DOI":"10.1016\/j.vaccine.2013.11.066"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.). 2021; 372: n71.","DOI":"10.1136\/bmj.n71"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Kuselman I, Schumacher I, Pennecchi F, Burns C, Fajgelj A, de Zorzi P. Long-term stability study of drug products and out-of-specification test results. Accreditation and Quality Assurance. 2011; 16: 615\u2013622.","DOI":"10.1007\/s00769-011-0813-y"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Huang TC, Chu G, Singh S. Analytical method development, validation, and out-of-specification investigations for polyethylene glycol. Journal of Pharmaceutical and Biomedical Analysis. 2023; 235: 115613.","DOI":"10.1016\/j.jpba.2023.115613"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Scott BS, Zhang K, Yehl PM, Yang SH. A strategic approach towards mass balance investigations in pharmaceutical drug substance release testing: A peculiar out of specification case study encountered during API manufacture. Journal of Pharmaceutical and Biomedical Analysis. 2024; 238: 115773.","DOI":"10.1016\/j.jpba.2023.115773"},{"key":"ref11","unstructured":"McDowall RD. Are You Invalidating Out-of-Specification (OOS) Results into Compliance? LCGC North America. 2020; 37: 411\u2013419."},{"key":"ref12","unstructured":"World Health Organization. Bangladesh Achieves International Recognition in Quality Testing for Medicines. 2020. Available at: https:\/\/www.who.int\/bangladesh\/news\/detail\/13-04-2020-bangladesh-achieves-international-recognition-in-quality-testing-for-medicines (Accessed: 13 March 2026)."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Mao X, Yang Y. Gap Analysis for Chinese Drug Control Institutes to Achieve the Standards of World Health Organization Medicine Prequalification. Journal of Pharmaceutical Sciences. 2017; 106: 652\u2013659.","DOI":"10.1016\/j.xphs.2016.09.023"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Wadhwa V, Rai S, Thukral T, Chopra M. Laboratory quality management system: road to accreditation and beyond. Indian Journal of Medical Microbiology. 2012; 30: 131\u2013140.","DOI":"10.4103\/0255-0857.96647"},{"key":"ref15","unstructured":"International Council for Harmonization. ICH harmonized guideline: validation of analytical procedures Q2(R2). ICH: Geneva. 2023."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Rambla-Alegre M, Esteve-Romero J, Carda-Broch S. Is it really necessary to validate an analytical method or not? That is the question. Journal of Chromatography A. 2012; 1232: 101\u2013109.","DOI":"10.1016\/j.chroma.2011.10.050"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Huang HL, Lee CW, Chang PY, You HL, Yu P. Developing a competency framework for medical laboratory scientists in Taiwan: a modified Delphi approach. BMC Medical Education. 2026; 26: 771.","DOI":"10.1186\/s12909-026-09191-x"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"McDowall RD. An Enhanced Approach to Analytical Instrument and System Qualification. Spectroscopy. 2025; 40: 6\u201311.","DOI":"10.56530\/spectroscopy.ne7878t3"},{"key":"ref19","unstructured":"Vuolo-Schuessler L, Newton ME, Smith P, Burgess C, McDowall RD. Harmonizing USP< 1058> and GAMP for analytical instrument qualification. Pharmaceutical Engineering. 2014; 34: 1\u20138."},{"key":"ref20","unstructured":"United States Pharmacopeia. General chapter <1058> analytical instrument qualification. United States Pharmacopeial Convention Inc.: Rockville. 2024."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Chikwendu OC, Chima AS, Edith MC. The optimization of overall equipment effectiveness factors in a pharmaceutical company. Heliyon. 2020; 6: e03796.","DOI":"10.1016\/j.heliyon.2020.e03796"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Lozier T. Streamline your CAPA process: use risk assessment to improve quality and compliance. The Quality Assurance Journal. 2010; 13: 37\u201340.","DOI":"10.1002\/qaj.476"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Marques-Garcia F, Garcia-Codesal MF, Caro-Narros MR, Contreras-SanFeliciano T. Importance of implementing an analytical quality control system in a core laboratory. Revista De Calidad Asistencial: Organo De La Sociedad Espanola De Calidad Asistencial. 2015; 30: 302\u2013309.","DOI":"10.1016\/j.cali.2015.07.007"},{"key":"ref24","unstructured":"Harden S, Longden H, Hill E, Analytical B. Change management in pharmaceutical quality control laboratories [White paper]. Waters Corporation: Milford, MA. Available at: https:\/\/www.pharmaceuticalonline.com\/doc\/change-management-in-pharmaceutical-quality-control-laboratories-0001 (Accessed: 13 March 2026)."},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Gegechkori VI, Sukhanova AM, Belyavskiy NO, Ramenskaya GV. Implementation of modern quality management system requirements in the production management of reference standards for pharmaceuticals and medicine. Farmakonekonomika. Modern Pharmacoeconomics and Pharmacoepidemiology. 2025; 18: 330\u2013339.","DOI":"10.17749\/2070-4909\/farmakoekonomika.2025.311"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Patel K, Chotai N. Documentation and Records: Harmonized GMP Requirements. Journal of Young Pharmacists: JYP. 2011; 3: 138\u2013150.","DOI":"10.4103\/0975-1483.80303"},{"key":"ref27","unstructured":"A Step-by-Step GMP Tutorial on Sample Management and Chain of Custody in QC Laboratories. Available at: https:\/\/www.pharmagmp.in\/ (Accessed: 13 March 2026)."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Redrup MJ, Igarashi H, Schaefgen J, Lin J, Geisler L, Ben M'Barek M, et al. Sample Management: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team. The AAPS Journal. 2016; 18: 290\u2013293.","DOI":"10.1208\/s12248-016-9869-2"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Dakhole MR, Thombre KR, Gupta KR, Umekar MJ. Ensuring data integrity in the pharmaceutical lifecycle: Challenges, principles, and global implications. Annales Pharmaceutiques Francaises. 2026; 84: 175\u2013191.","DOI":"10.1016\/j.pharma.2025.10.002"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Charoo NA, Khan MA, Rahman Z. Data integrity issues in pharmaceutical industry: Common observations, challenges and mitigations strategies. International Journal of Pharmaceutics. 2023; 631: 122503.","DOI":"10.1016\/j.ijpharm.2022.122503"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Jaiswal H, Muddukrishna BS, Kulyadi GP. Data integrity violations: A challenge to the pharmaceutical industry. International Journal of Pharmaceutical Quality Assurance. 2020; 11: 196.","DOI":"10.25258\/ijpqa.11.1.30"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Gokulakrishnan D, Venkataraman S. Ensuring data integrity: Best practices and strategies in pharmaceutical industry. Intelligent Pharmacy. 2024; 2: 110\u2013120.","DOI":"10.1016\/j.ipha.2024.09.010"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Schr\u00f6der I, Huang DY, Ellis O, Gibson JH, Wayne NL. Laboratory safety attitudes and practices: A comparison of academic, government, and industry researchers. Journal of Chemical Health and Safety. 2016; 23: 12\u201323.","DOI":"10.1016\/j.jchas.2015.03.001"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Tran KT, Nguyen KD, Nguyen TN, Pham LT, Nguyen LM, Nguyen PH, et al. The role, challenges, and solutions of laboratories in disaster medicine: a systematic review. Frontiers in Public Health. 2026; 13: 1726280.","DOI":"10.3389\/fpubh.2025.1726280"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Tziakou E, Fragkaki AG, Platis A\u039d. Identifying risk management challenges in laboratories. Accreditation and Quality Assurance. 2023; 28: 167\u2013179.","DOI":"10.1007\/s00769-023-01540-3"},{"key":"ref36","unstructured":"Burgess C, McDowall RD. An integrated risk assessment for analytical instruments and computerized laboratory systems. Spectroscopy. 2013; 28: 1\u20137."},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Nichols JH. Laboratory quality control based on risk management. Annals of Saudi Medicine. 2011; 31: 223\u2013228.","DOI":"10.4103\/0256-4947.81526"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Venkatesh C, Puranik SB. Importance of self-inspection in pharmaceutical industry as per various regulatory guidelines. Biomedical & Pharmacology Journal. 2018; 11: 387.","DOI":"10.13005\/bpj\/1384"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Scully H, O'Sullivan F. Development of the Self-Inspection Programme to Assist Demonstrating PQS Effectiveness. Level 3. 2020; 15: 11.","DOI":"10.21427\/zqm6-8z87"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Agarwal P, Mishra A. Pharmaceutical quality audits a review. International Journal of Applied Pharmaceutics. 2019; 11: 14\u201322.","DOI":"10.22159\/ijap.2019v11i1.29709"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Linna A, Korhonen M, Airaksinen M, Juppo AM. Experiences of using the GMP audit preparation tool in pharmaceutical contract manufacturer audits. Drug Development and Industrial Pharmacy. 2010; 36: 632\u2013637.","DOI":"10.3109\/03639040903406134"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Blaschke TF, Lumpkin M, Hartman D. The World Health Organization Prequalification Program and Clinical Pharmacology in 2030. Clinical Pharmacology and Therapeutics. 2020; 107: 68\u201371.","DOI":"10.1002\/cpt.1680"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Umaru OT, Adeyemi AS, Aderonmu O, Bhangu BS, Dhaliwal HS, Lim H, et al. Global Pharmaceutical Regulation: Comparative Frameworks and Operations. Pharmacy (Basel, Switzerland). 2026; 14: 50.","DOI":"10.3390\/pharmacy14020050"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Pourraz J. Making medicines in post-colonial Ghana: State policies, technology transfer and pharmaceuticals market. Social Science & Medicine (1982). 2022; 311: 115360.","DOI":"10.1016\/j.socscimed.2022.115360"},{"key":"ref45","unstructured":"World Health Organization. List of WHO prequalified quality control laboratories. 2023. Available at: https:\/\/extranet.who.int\/prequal\/medicines\/prequalified\/quality-control-labs (Accessed: 19 May 2026)."},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Nabirova D, Schmid G, Yusupova R, Kantarbayeva M, Ismailov SI, Moffett D, et al. Assessment of the quality of anti-tuberculosis medicines in Almaty, Kazakhstan, 2014. The International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union against Tuberculosis and Lung Disease. 2017; 21: 1161\u20131168.","DOI":"10.5588\/ijtld.17.0074"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Kohar TH, Munemo E, Kpaka J, Marles N, Akwiwu-Ibe O, Dahourou AG, et al. Strengthening governance and leadership of the national laboratory system in Liberia: achievements and challenges. Frontiers in Public Health. 2025; 13: 1504451.","DOI":"10.3389\/fpubh.2025.1504451"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Babalola CP, Kotila O, Samuel BB, Adetunji O, Gbotosho GO, Moody JO, et al. Building capacity for drug development process in Africa\u2012A workable model. Pharmacy Education. 2024; 24: 1\u20132.","DOI":"10.46542\/pe.2024.241.112"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"'t Hoen EFM, Hogerzeil HV, Quick JD, Sillo HB. A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme. Journal of Public Health Policy. 2014; 35: 137\u2013161.","DOI":"10.1057\/jphp.2013.53"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Lehnert R, Mbaeliachi N, R\u00e4go L. WHO prequalification of medicines at 25: Celebrating a unique achievement in a changing landscape. British Journal of Clinical Pharmacology. 2026; 92: 2976\u20132977.","DOI":"10.1002\/bcp.70626"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Hajjou M, Krech L, Lane-Barlow C, Roth L, Pribluda VS, Phanouvong S, et al. Monitoring the quality of medicines: results from Africa, Asia, and South America. The American Journal of Tropical Medicine and Hygiene. 2015; 92: 68\u201374.","DOI":"10.4269\/ajtmh.14-0535"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Ozawa S, Higgins CR, Yemeke TT, Nwokike JI, Evans L, Hajjou M, et al. Importance of medicine quality in achieving universal health coverage. PloS One. 2020; 15: e0232966.","DOI":"10.1371\/journal.pone.0232966"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Nkengasong JN, Yao K, Onyebujoh P. Laboratory medicine in low-income and middle-income countries: progress and challenges. Lancet (London, England). 2018; 391: 1873\u20131875.","DOI":"10.1016\/S0140-6736(18)30308-8"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Alfonso CP, N'Jambong GB, Magdy A, Di Trapani L, Kuwana R, Kahsay AG, et al. Identifying and costing common gaps in Central and West Africa pharmaceutical regulation. Frontiers in Medicine. 2024; 11: 1362253.","DOI":"10.3389\/fmed.2024.1362253"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Basil B, Eze OE. Strengthening laboratory quality through risk-based thinking: Implementation challenges and opportunities in Nigeria. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2026; 589: 121041.","DOI":"10.1016\/j.cca.2026.121041"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Mekasha YT, Tilahun M, Tegegne AA, Abraham M, Mekonnen AW, Feleke MG. Drivers and strategies to combat substandard and falsified medicines in low- and middle-income countries: A systematic review of qualitative evidence. The Journal of Medicine Access. 2026; 10: 27550834261435773.","DOI":"10.1177\/27550834261435773"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Husaini DC, Bolon F, Smith N, Reynolds R, Humes S, Cayetano V. Quality of medicines and public health in Latin America and the Caribbean: a review. International Journal of Pharmaceutical and Healthcare Marketing. 2023; 17: 654\u2013674.","DOI":"10.1108\/IJPHM-07-2022-0061"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Adhao V, Ambhore J, Chaudhari S. Transforming pharmaceutical quality assurance and validation through artificial intelligence. Artificial Intelligence in Health. 2026; 3: 18\u201328.","DOI":"10.36922\/aih025160032"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Abdulhussain R, Muhamad H, Fiza T, Dereiah S, Mawla N, Patel K, et al. The integration of artificial intelligence through quality by digital design for sustainable pharmaceutical manufacturing. International Journal of Pharmaceutics. 2026; 693: 126682.","DOI":"10.1016\/j.ijpharm.2026.126682"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Miozza M, Brunetta F, Appio FP. Digital transformation of the Pharmaceutical Industry: A future research agenda for management studies. Technological Forecasting and Social Change. 2024; 207: 123580.","DOI":"10.1016\/j.techfore.2024.123580"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Chauhan SB, Singh I, Gaur R, Jain C. Strategic Integration of Electronic Quality Management Systems with Quality Risk Management: Advancing Pharmaceutical Compliance and Operational Excellence. Current Pharmaceutical Design. 2026.  (in press)","DOI":"10.2174\/0113816128430008251210175444"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Niyibizi J, Mugisha J, Songa B, Nizeyimana E, Isimbi DB. Pharmaceutical regulatory harmonization in Africa: a scoping review of policy design, implementation approaches, and outcomes. Frontiers in Medicine. 2026; 13: 1812798.","DOI":"10.3389\/fmed.2026.1812798"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Lakkis MM. Global and Regional Drug Regulatory Harmonization Initiatives. Drug Information Journal: DIJ \/ Drug Information Association. 2010; 44: 289\u2013297.","DOI":"10.1177\/009286151004400311"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Lindstr\u00f6m-Gommers L, Mullin T. International Conference on Harmonization: Recent Reforms as a Driver of Global Regulatory Harmonization and Innovation in Medical Products. Clinical Pharmacology and Therapeutics. 2019; 105: 926\u2013931.","DOI":"10.1002\/cpt.1289"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Dispas A, Sacr\u00e9 PY, Ziemons E, Hubert P. Emerging analytical techniques for pharmaceutical quality control: Where are we in 2022? Journal of Pharmaceutical and Biomedical Analysis. 2022; 221: 115071.","DOI":"10.1016\/j.jpba.2022.115071"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Zacharis CK, Markopoulou CK. Recent Trends in Pharmaceutical Analytical Chemistry. Molecules (Basel, Switzerland). 2020; 25: 3560.","DOI":"10.3390\/molecules25163560"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Wang T, Cauchon NS, Kirwan JP, Joubert MK, Algorri M, Bell B, et al. Advancing the implementation of innovative analytical technologies in pharmaceutical manufacturing-Some regulatory considerations. Journal of Pharmaceutical Sciences. 2025; 114: 816\u2013828.","DOI":"10.1016\/j.xphs.2024.12.025"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Lezotre PL. Value and influencing factors of the cooperation, convergence, and harmonization in the pharmaceutical sector. International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations. 2014; 171.","DOI":"10.1016\/B978-0-12-800053-3.00003-3"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Masini T, Mac\u00e9 C, Heide L, Hamill H, Hampshire K, Newton PN, et al. Out of the boxes, out of the silos: The need of interdisciplinary collaboration to reduce poor-quality medical products in the supply chain. Research in Social & Administrative Pharmacy: RSAP. 2022; 18: 3694\u20133698.","DOI":"10.1016\/j.sapharm.2022.03.006"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Skerritt JH, Mayer M, Francer J. Strengthening the Use of International Collaborative Regulatory Assessments and Regulatory Alignment- Implications for Global Convergence. Therapeutic Innovation & Regulatory Science. 2025; 59: 993\u20131003.","DOI":"10.1007\/s43441-025-00817-8"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Weresa MA, Tomeczek AF, Hegerty SW. International collaboration in research: insights from pharmaceutical multinationals. The Journal of Technology Transfer. 2026; 1\u201335.","DOI":"10.1007\/s10961-026-10330-1"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Lee KS, Ming LC, Lean QY, Yee SM, Patel R, Taha NA, et al. Cross-border Collaboration to Improve Access to Medicine: Association of Southeast Asian Nations Perspective. Journal of Epidemiology and Global Health. 2019; 9: 93\u201397.","DOI":"10.2991\/jegh.k.190506.001"}],"container-title":["Pharmazie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/Pharmazie\/81\/9\/10.31083\/Pharmazie51355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:06:11Z","timestamp":1790701571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/Pharmazie\/81\/9\/10.31083\/Pharmazie51355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S3053-691X(26)04616-0"],"URL":"https:\/\/doi.org\/10.31083\/pharmazie51355","relation":{},"ISSN":["0031-7144","3053-691X"],"issn-type":[{"value":"0031-7144","type":"print"},{"value":"3053-691X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"51355"}}